AXL and colorectal cancer: AXL dimerizes with epidermal growth factor receptor (EGFR) (Elkabets et al., 2015), which has been shown to regulate FOXM1 expression via an EGFR/RAS/FOXM1/β-catenin axis in colorectal cancer (Valverde et al., 2017).